ARTV Artiva Biotherapeutics, Inc. - Common Stock
$11,78
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$2–$15
78% of range
Calificación del Analista
BUY
12 analysts
Precio Objetivo
$36
+204% upside
P/E (TTM)
-1.3
ROE
—
Margen de Beneficio Neto
—
ARTV Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$11.78
Capitalización Bursátil
—
P/E (TTM)
-1.3
BPA (TTM)
$-3.43
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$2 – $15
ARTV Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2023-12-31
→
2025-12-31
BPA
$-3.43
2023-12-31
→
2025-12-31
Flujo de caja libre
—
2024-12-31
→
2024-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ARTV
Mediana de Pares
P/E (TTM)
-1.3
19.6
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ARTV
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ARTV
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ARTV
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-99.2%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ARTV
Mediana de Pares
ARTV Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
12 analistas
- Compra fuerte 4 33,3%
- Compra 7 58,3%
- Mantener 1 8,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-18
Mediana
$40.00
Media
$35.80
← Por Debajo de Todos los Objetivos
$11.78
Mín
$23.00
Máx
$41.00
Objetivo mediano
$40.00
+239,6%
Objetivo medio
$35.80
+203,9%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.01%
Próximo informe
Ago 27, 2026
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.63 | $-0.64 | 0.01% |
| 31 de marzo de 2026 | $-0.95 | $-0.89 | -0.06% |
| 31 de diciembre de 2025 | $-0.85 | $-0.84 | -0.01% |
| 30 de septiembre de 2025 | $-0.88 | $-0.89 | 0.01% |
| 30 de junio de 2025 | $-0.87 | $-0.82 | -0.05% |
| 31 de marzo de 2025 | $-0.83 | $-0.72 | -0.11% |
| 31 de diciembre de 2024 | $-0.66 | $-0.77 | 0.11% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ARTV | — | -1.3 | -99.2% | — | — | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-87M | · | $-81M | $-77M | $-70M | · | $-38M | $-32M | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | |
| P/E | -2.9 | -1.8 | · | -0.8 | -0.1 | -0.1 | · | -0.4 | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | |
| P / FCF | · | -7.5 | · | · | · | -3.6 | · | · | · | · | · | |
| Earnings Yield | -34.3% | -54.8% | · | -122.0% | -1630.5% | -1366.3% | · | -249.4% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $0 | $251.0K | $33M |
| Margen Operativo % | — | -26805.6% | — |
| Beneficio neto | $-84M | $-65M | $-29M |
| EPS Diluido | $-3.43 | $-5.81 | $-35.78 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | — | 15.4 | — |
| Ratio Rápido | — | 15.1 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | — | $-56M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 75 declarantes · $384.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 42 (+32 vs trimestre anterior) | 7 (+2 vs trimestre anterior) | 20 (+19 vs trimestre anterior) | 4 (-8 vs trimestre anterior) | +23.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174 169 727 | 17 955 642 | 45,32% | Acciones |
| VIKING GLOBAL INVESTORS LP | $25 260 410 | 2 604 166 | 6,57% | Acciones |
| Blackstone Inc. | $23 313 339 | 2 403 437 | 6,07% | Acciones |
| 5AM Venture Management, LLC | $22 827 049 | 2 353 304 | 5,94% | Acciones |
| Venrock Adviser, LLC | $19 822 881 | 2 043 596 | 5,16% | Acciones |
| FRANKLIN RESOURCES INC | $19 373 063 | 1 997 223 | 5,04% | Acciones |
| Caligan Partners LP | $16 840 277 | 1 736 111 | 4,38% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 523 606 | 981 815 | 2,48% | Acciones |
| SAMSARA BIOCAPITAL, LLC | $9 262 152 | 954 861 | 2,41% | Acciones |
| Blue Owl Capital Holdings LP | $8 483 057 | 874 542 | 2,21% | Acciones |
| Propel Bio Management, LLC | $6 755 429 | 696 436 | 1,76% | Acciones |
| CITADEL ADVISORS LLC | $5 910 947 | 609 376 | 1,54% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5 092 500 | 525 000 | 1,33% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $3 049 438 | 314 375 | 0,79% | Acciones |
| Nantahala Capital Management, LLC | $2 910 000 | 300 000 | 0,76% | Acciones |
| Revelation Capital Management, LLC | $2 903 317 | 299 311 | 0,76% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $2 834 361 | 292 032 | 0,74% | Acciones |
| Alyeska Investment Group, L.P. | $2 654 066 | 273 615 | 0,69% | Acciones |
| ACUTA CAPITAL PARTNERS, LLC | $2 526 035 | 260 416 | 0,66% | Acciones |
| KVP Capital Advisors, LP | $1 940 000 | 200 000 | 0,50% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 882 848 | 194 108 | 0,49% | Acciones |
| UBS Group AG | $1 757 019 | 181 136 | 0,46% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $1 697 500 | 175 000 | 0,44% | Acciones |
| STATE STREET CORP | $1 607 911 | 165 764 | 0,42% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 464 700 | 151 000 | 0,38% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 439 412 | 148 393 | 0,37% | Acciones |
| ADAR1 Capital Management, LLC | $1 150 653 | 118 624 | 0,30% | Acciones |
| Simplify Asset Management Inc. | $983 144 | 101 355 | 0,26% | Acciones |
| VANGUARD GROUP INC | $890 973 | 207 686 | 0,23% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824 500 | 85 000 | 0,21% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $762 178 | 78 575 | 0,20% | Acciones |
| DAFNA Capital Management LLC | $650 880 | 67 101 | 0,17% | Acciones |
| Quadrature Capital Ltd | $478 647 | 49 345 | 0,12% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $434 686 | 44 813 | 0,11% | Acciones |
| XTX Topco Ltd | $412 337 | 42 509 | 0,11% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301 796 | 31 113 | 0,08% | Acciones |
| Velan Capital Investment Management LP | $242 500 | 25 000 | 0,06% | Acciones |
| Atom Investors LP | $221 684 | 22 854 | 0,06% | Acciones |
| BAILARD, INC. | $200 790 | 20 700 | 0,05% | Acciones |
| Nuveen Asset Management, LLC | $187 599 | 18 611 | 0,05% | Acciones |
| Spark Investment Management LLC | $160 050 | 16 500 | 0,04% | Acciones |
| GOLDMAN SACHS GROUP INC | $153 066 | 15 780 | 0,04% | Acciones |
| Squarepoint Ops LLC | $144 094 | 14 855 | 0,04% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $135 606 | 13 980 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $116 187 | 11 978 | 0,03% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115 391 | 11 896 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $59 170 | 6 100 | 0,02% | Acciones |
| Russell Investments Group, Ltd. | $53 263 | 5 491 | 0,01% | Acciones |
| State of Wyoming | $44 504 | 4 588 | 0,01% | Acciones |
| WELLS FARGO & COMPANY/MN | $38 606 | 3 980 | 0,01% | Acciones |
| FMR LLC | $34 513 | 3 558 | 0,01% | Acciones |
| RHUMBLINE ADVISERS | $29 474 | 3 039 | 0,01% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20 719 | 2 136 | 0,01% | Acciones |
| Federation des caisses Desjardins du Quebec | $19 400 | 2 000 | 0,01% | Acciones |
| JPMORGAN CHASE & CO | $18 422 | 1 923 | 0,00% | Acciones |
| CITIGROUP INC | $18 188 | 1 875 | 0,00% | Acciones |
| China Universal Asset Management Co., Ltd. | $15 520 | 1 600 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $11 136 | 1 148 | 0,00% | Acciones |
| NORTHERN TRUST CORP | $6 955 | 717 | 0,00% | Acciones |
| BlackRock, Inc. | $5 781 | 596 | 0,00% | Acciones |
| Legal & General Group Plc | $5 490 | 566 | 0,00% | Acciones |
| Steward Partners Investment Advisory, LLC | $4 850 | 500 | 0,00% | Acciones |
| BARCLAYS PLC | $4 792 | 494 | 0,00% | Acciones |
| Ameritas Investment Partners, Inc. | $4 084 | 421 | 0,00% | Acciones |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | $3 880 | 400 | 0,00% | Acciones |
| Tower Research Capital LLC (TRC) | $2 396 | 247 | 0,00% | Acciones |
| US BANCORP \DE\ | $2 280 | 235 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $2 000 | 224 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $1 940 | 200 | 0,00% | Acciones |
| Quarry LP | $912 | 94 | 0,00% | Acciones |
| Sterling Capital Management LLC | $698 | 72 | 0,00% | Acciones |
| MORGAN STANLEY | $398 | 41 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $221 | 22 940 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $126 | 13 | 0,00% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $106 | 11 | 0,00% | Acciones |
Informantes de la empresa 9 insiders · 8 directivos · 2 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | 19 de mayo de 2026 S | 1 535 082 | 0 | 3 | $-284 985 |
| Thad Allen Huston | Chief Financial Officer | 10 de marzo de 2026 A | 220 000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | 15 de noviembre de 2025 F | 99 356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | 18 de mayo de 2026 A | 77 500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | 19 de mayo de 2026 S | 337 920 | 0 | 1 | $-79 198 |
| Subhashis Banerjee | Chief Medical Officer | 19 de mayo de 2026 S | 144 963 | 0 | 1 | $-63 403 |
| Heather Raymon | SVP, Research and Development | 19 de mayo de 2026 S | 148 228 | 0 | 1 | $-27 886 |
| Christopher Horan | Chief Tech Operations Officer | 19 de mayo de 2026 S | 293 450 | 0 | 1 | $-63 088 |
| Elaine K. Sorg | Consejero | 18 de febrero de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 23 de julio de 2026 | 37,90% | Enmienda | — | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | 28 de mayo de 2026 | 12,30% | Enmienda | — | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | 29 de julio de 2024 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 11 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 15 784 SH | 8 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,00% | 35 800 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 137 793 SH | 8 de agosto de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 3 029 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 269 149 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 699 899 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26 837 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 934 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 342 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,00% | 176 SH | 8 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 678 NS | 30 de abril de 2026 | N-PORT |